Within the last quarter, GE HealthCare Techs (NASDAQ:GEHC) has received analyst ratings that range from bullish to bearish. Out of the six analysts who have offered 12-month price targets, the company has an average price target of $80.67, with a high of $90.00 and a low of $76.00.
Analyst ratings are assessments provided by specialists in banking and financial systems. These analysts research company financial statements, attend conferences and meetings, and communicate with insiders to determine their ratings for specific stocks or sectors. Typically, these ratings are updated quarterly.
In the past three months, GE HealthCare Techs has received one bullish rating, one somewhat bullish rating, four indifferent ratings, and no bearish ratings. These ratings indicate a mixture of opinions among analysts, where a higher number of bullish ratings suggests a positive outlook for the stock, while a higher number of bearish ratings indicates a negative sentiment.
Investors who rely on analyst ratings should note that these recommendations are made by humans and may be subject to error. Some analysts also provide forecasts for metrics such as growth estimates, earnings, and revenue, which can provide additional guidance for investors.
It is worth mentioning that the average price target for GE HealthCare Techs has increased by 6.14% over the past month. This reflects a potentially positive trend in the analysts’ projections for the company’s future performance.
For those interested in staying updated on the latest analyst ratings for GE HealthCare Techs, it is advisable to regularly check reputable financial sources for the most accurate and up-to-date information.
Sources:
– Benzinga’s automated content engine
– Reviewed by an editor
